B1IL45 AF NFT

6,7-dimethyl-8-ribityllumazine synthase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeid6vu3bhrzelvh7rz2xdfeusml5qbkm5p3cokeaoogg6mpbowmxni/metadata.json
IPFS of structure file: 
bafybeigw7p5xonmkmqpkzawk4u5iruc6nwjf7kyjkqbxv6n6dydrjvag7q/AF-B1IL45-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xbF8467B100eddcD57b40BcA629dAe7126b34CBf1
First NFT owner address (bech32): 
genesis1h7zx0vgqahwd276qhjnznkh8zf4nfjl3dmyghh
Current NFT ID #346439 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
346439
Accession (UniProt):
B1IL45
Name::
6,7-dimethyl-8-ribityllumazine synthase
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Okra / Type B1)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B1IL45 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B1IL45|RISB_CLOBK 6,7-dimethyl-8-ribityllumazine synthase OS=Clostridium botulinum (strain Okra / Type B1) OX=498213 GN=ribH PE=3 SV=1 MKIYEGKLTAEGLKVGIIVSRFNEFITSKLLAGSIDCLKRHGAKEDNIEVCWVPGAFEIPVIAKKMASKGKYDAVICLGAVIRGATPHFDYVSSEVSKGVAHVSLDKEVPVIFGVLTTDTIEQAIERAGTKAGNKGYDAAMSAIEMSNLMKVLD